Algo version: 0.98b
CellaVision AB (publ) is listed at the STO Exchange
CellaVision AB (publ) [CEVI.ST]
STO Sector: Healthcare Industry:Medical Devices

Is CellaVision AB (publ) stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, CellaVision AB (publ) pays dividends. Last time was Monday 13th of May 2024 where the investors holding the stock on Monday 6th of May 2024 were paid SEK2.25 per share. Over the last 13 times between 2012 and 2024, CellaVision AB (publ) has paid SEK17.05 with an average of SEK1.31 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for CellaVision AB (publ) 10 years ago, but if you had invested on Monday 9th of September 2019 when the price was SEK321.00, you would have made a loss of SEK-51.00 per share or -15.89%

Yes, the average daily trading liquidity for CellaVision AB (publ) is SEK14 233 thousand. You should therefore be able to get in and out of your positions relatively fast.

CellaVision AB (publ) has a normal ratio of the business financed by loans. This puts the company at some risk in periods of high inflation where borrowing costs usually go up. With a high cash flow to debt ratio of 2.32, the company's ability to pay off the debt is good. CellaVision AB (publ) has a good net profit margin of 19.94% and should have high tolerances against inflation.

We have calculated the inflation risk for CellaVision AB (publ) to be low [0.25 of 1]

US inflation for July 2024 was 0.15%. Over the last 12 months, the US inflation is 2.92%. The 10-year treasury yield that indicates the future interest level is currently 3.72 and is down -0.95 over the last 30 days.